Search results
Investing in Taysha Gene Therapies Inc
Knox Daily· 6 days agoB now holds 16,466,667 shares, worth roughly $50.88 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...
The price of hope: CAR-T therapy in pediatric leukemia
Medical Xpress· 6 days agoWe stand at the crossroads of medical innovation, where cutting-edge scientific discoveries...
Chairman, President & CEO Mates Sharon sold 20,565 shares of Intra-Cellular Therapies Inc [ITCI] –...
Knox Daily· 2 days agoUpon closing the transaction, the insider’s holdings decreased to 7,345 shares, worth approximately $0.0. As published in their initiating research note from Robert W. Baird ...
Perspective Therapeutics Inc [CATX] Shares Jump Approximately 192.16% Over the Year – Knox Daily
Knox Daily· 3 days agoAs published in their initiating research note from Cantor Fitzgerald on May 09, 2024, Perspective Therapeutics Inc [CATX...1.4200, which, if violated, would cause prices ...
Savara (NASDAQ:SVRA) Price Target Cut to $7.00
ETF DAILY NEWS· 6 days agoSavara (NASDAQ:SVRA – Free Report) had its price objective cut by Evercore ISI from $10.00 to $7.00 in a research note issued to investors on Thursday morning ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Kelly Price Says She’s Not “A Diddy Cheerleader” After Facing Backlash For Her Now-Deleted “Prayer”
VIBE via Yahoo News· 6 days agoI have nothing to do with that.” In regards to the video of Diddy assaulting his ex-girlfriend, ...
Kelly Price Is Not ‘A Diddy Cheerleader’ After Comment on His Apology
US Weekly· 6 days agoSinger Kelly Price is clarifying her comment offering “prayers” for Sean “Diddy” Combs after his...
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to Hold by StockNews.com
ETF DAILY NEWS· 2 days agoCantor Fitzgerald restated an overweight rating and issued a $173.00 price target on shares of Ascendis Pharma A/S in a research note on Wednesday, May ...
Needham & Company LLC Reaffirms Buy Rating for Celcuity (NASDAQ:CELC)
ETF DAILY NEWS· 7 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $24.00